Workflow
Power Metallic Appoints Retired Federal Minister Seamus O'Regan to Board
Prnewswire· 2025-08-26 11:00
Former Minister of Energy & Natural Resources, Indigenous Services, Seniors, Labour, Veteran Affairs and Associate Minister of National DefenceTORONTO, Aug. 26, 2025 /PRNewswire/ - Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) (Frankfurt: IVV) Power Metallic is pleased to announce the appointment of Seamus O'Regan to its board.Seamus O'Regan Jr joined Stewart McKelvey, Atlantic Canada's largest law firm, in March of 2025 as Senior Business Advisor following a dist ...
Kirkland Lake Discoveries Expands Mineralized System with Semi-Massive to Massive Sulphide Intersections in Three Additional Holes at KL West Property
Newsfile· 2025-08-26 11:00
Kirkland Lake Discoveries Expands Mineralized System with Semi-Massive to Massive Sulphide Intersections in Three Additional Holes at KL West PropertyAugust 26, 2025 7:00 AM EDT | Source: Kirkland Lake Discoveries Corp.Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Kirkland Lake Discoveries (TSXV: KLDC) (OTCID: KLKLF) ("KLDC" or the "Company") is pleased to report that recent drilling at the KL West Property has expanded the mineralized system, with three additional holes intersecting ...
Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship
Globenewswire· 2025-08-26 11:00
Separately Secures Access to OneGI Through Brentwood Pharmacy Agreement Gimoti Specialty Pharmacy Network to Almost Double with Additional Relationships SOLANA BEACH, Calif. and CHICAGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on developing treatments for gastrointestinal (GI) diseases, with a particular emphasis on GIMOTI® (metoclopramide) nasal spray, together with EVERSANA, a leading provider of global commercial services to the life ...
DFDS ENTERS BALTIC SEA SPACE CHARTER AGREEMENT
Globenewswire· 2025-08-26 11:00
INVESTOR NEWS no. 28 - 26 August 2025 Space charter agreement with TT Line covering freight and passengersAgreement covers DFDS route Klaipeda-KarlshamnDFDS also granted access to capacity on TT Line routes Klaipeda-Trelleborg and Klaipeda-TravemündeAgreement expected to be effective from 1 October 2025 To enhance the efficiency and scope of our Baltic Sea ferry network, DFDS has today entered into a mutual space charter agreement with TT Line on the combined freight and passenger (RoPax) route Karlshamn- ...
Voyager to Present at Upcoming Investor Conferences
Globenewswire· 2025-08-26 11:00
LEXINGTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that the company will participate in the following upcoming investor conferences: Citi's 2025 Biopharma Back to School Conference: Fireside chat at 4:00 p.m. ET on Tuesday, September 2, 2025, in Boston, MA, during which the company plans to highlight preclinical data supporting its non-viral delivery platform l ...
Marker Therapeutics Provides Update on Phase 1 APOLLO Study Highlighting Encouraging Overall Response Rates in Relapsed Lymphoma
Globenewswire· 2025-08-26 11:00
Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphoma showed 66% of Non-Hodgkin Lymphoma (NHL) patients achieving objective response rates, with 50% demonstrating complete response (CR) Favorable safety profile observed in study participants with no dose limiting toxicities (DLTs) or immune-effector cell associated neurotoxicity syndrome (ICANS) in the dose escalation cohort Dose expansion phase of study will investigate MT-601 at pre-specified maximum dose in patients ...
Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
Globenewswire· 2025-08-26 11:00
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 2025 Cantor Global Healthcare Conference on Wednesday, September 3 at 2:45-3:15 PM ET. The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archi ...
NameSilo Technologies Announces Acquisition of ShortURL by NameSilo LLC, Appointment of New Director, and Grants of Stock Options and Restricted Share Units
Prnewswire· 2025-08-26 11:00
CSE: URL / OTC: URLOFVANCOUVER, BC, Aug. 26, 2025 /PRNewswire/ -Acquisition of ShortURL NameSilo Technologies Corp. (CSE: URL) (PINKSHEETS: URLOF) (the "Company") is pleased to announce that its wholly owned subsidiary, NameSilo LLC, has acquired 100% of ShortURL.at, one of the most highly ranked platforms in the global link shortening space.With over 5.8 million active domains under management, NameSilo continues to execute on its strategy of acquiring and integrating complementary internet infrastructure ...
Helium Evolution Announces $8.3 Million Convertible Note to Fund Soda Lake Helium Production Facility and Drilling Campaign
Globenewswire· 2025-08-26 11:00
CALGARY, Alberta, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Helium Evolution Incorporated (TSXV:HEVI) ("HEVI" or the "Company"), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, is pleased to announce that it has entered into an agreement with ENEOS Xplora Inc. (“ENEOS Xplora”) through its affiliated company, ENEOS Xplora USA Limited (“ENEOS USA”), pursuant to which ENEOS USA has agreed to purchase a convertible note with a face value of $8.3 million (the “Note”). T ...
Balchem Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025
Globenewswire· 2025-08-26 11:00
MONTVALE, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference. About Balchem Corporation B ...